» Articles » PMID: 25447040

Cost-utility Analysis of Treating out of Hospital Cardiac Arrests in Jerusalem

Overview
Journal Resuscitation
Specialty Emergency Medicine
Date 2014 Dec 3
PMID 25447040
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Out-of-hospital cardiac arrest (OHCA) initiates a chain of responses including emergency medical service mobilization and medical treatment, transfer and admission first to a hospital Emergency Department (ED) and then usually to an intensive care unit and ward. Costly pre- and in-hospital care may be followed by prolonged post discharge expenditure on treatment of patients with severe neurological sequelae. We assessed the cost-effectiveness of treatment of OHCA by calculating the cost per Disability Adjusted Life Year (DALY) averted.

Methods And Results: We studied 3355 consecutive non-traumatic OHCAs (2005-2010) in Jerusalem, Israel, supplemented by hospital utilization data extracted from patient files (n = 570) and post-discharge follow-up (n = 196). Demographic, utilization and economic data were incorporated into a spreadsheet model to calculate the cost-utility ratio. Advanced life support was administered to 2264 of the 3355 OHCAs (67.5%) and 1048 (45.6%) patients were transferred to the ED. Of 676 (20.1%) patients who survived the ED and were admitted, there were 206 (6.1%) survivors to discharge, among them only 113 (3.4%) neurologically intact. Total cost ($39,100,000) per DALY averted (1353) was $28,864.

Conclusions: The current package of OHCA interventions in Jerusalem appears to be very cost-effective as the cost per averted DALY of $28,864 is less than the Gross Domestic Product per capita ($33,261). This paper provides a basis for studying the effects of potential interventions that can be evaluated in terms of their incremental costs per averted DALY for treatment of OHCA.

Citing Articles

A systematic review of cost-effectiveness of treating out of hospital cardiac arrest and the implications for resource-limited health systems.

Werner K, Hirner S, Offorjebe O, Hosten E, Gordon J, Geduld H Int J Emerg Med. 2024; 17(1):151.

PMID: 39385075 PMC: 11465730. DOI: 10.1186/s12245-024-00727-w.


A Systematic Review of Cost-Effectiveness of Treating Out of Hospital Cardiac Arrest: Implications for Resource-limited Health Systems.

Werner K, Hirner S, Offorjebe O, Hosten E, Gordon J, Geduld H Res Sq. 2024; .

PMID: 38883781 PMC: 11177998. DOI: 10.21203/rs.3.rs-4402626/v1.


Cost-utility analysis of prenatal diagnosis of congenital cardiac diseases using deep learning.

Ginsberg G, Drukker L, Pollak U, Brezis M Cost Eff Resour Alloc. 2024; 22(1):44.

PMID: 38773527 PMC: 11110271. DOI: 10.1186/s12962-024-00550-3.


The Public Health and Economic Impact of Drug Overdose Out-of-Hospital Cardiac Arrest in the United States.

Coute R, Nathanson B, Shekhar A, White C, Kurz M, Jackson E Prehosp Emerg Care. 2024; :1-7.

PMID: 38451237 PMC: 11427595. DOI: 10.1080/10903127.2024.2327526.


Successful treatment of out-of-hospital cardiac arrest is still based on quick activation of the chain of survival.

Borgstedt L, Schaller S, Goudkamp D, Fuest K, Ulm B, Jungwirth B Front Public Health. 2023; 11:1126503.

PMID: 37113172 PMC: 10126244. DOI: 10.3389/fpubh.2023.1126503.